Dendrobium huoshanense attenuates Parkinsonian neurodegeneration via dual antioxidant and anti-inflammatory pathways.
Yan C, Liu Y, Hong S, Gu Z, Li Q
Summary
PubMedA traditional Chinese medicinal herb called Dendrobium huoshanense shows promise in treating Parkinson's disease by reducing inflammation and oxidative stress in brain cells. Four-year-old plants were most effective, suggesting that plant maturity impacts therapeutic potential.
chevron_right Technical Details
Key Findings
Four-year-old Dendrobium huoshanense exhibited the highest content of active compounds and significantly alleviated motor deficits in MPTP-induced PD mice
DH suppressed the NF-κB/NLRP3 inflammatory pathway while activating the HO-1/Nrf2 antioxidant pathway in both neuronal and microglial cells
Longer growth periods enhanced efficacy, with four-year plants demonstrating superior neuroprotective activity compared to one-to-three-year-old specimens
Original Abstract
Dendrobium huoshanense (DH), a traditional Chinese medicinal herb, is traditionally used for its anti-inflammatory and antioxidant properties, suggesting potential against neurodegenerative diseases like Parkinson's disease (PD). This study investigated how growth years affect DH's chemical composition and neuroprotective activities against PD, focusing on anti-inflammatory and antioxidant mechanisms. DH extracts from different growth years (N1-N4) were analyzed chemically. Their effects were evaluated in D-galactose-stimulated PC12 cells and LPS-activated BV-2 microglia. The most potent four-year-old DH was further tested in an MPTP-induced PD mouse model using behavioral tests, immunohistochemistry, and Western blotting. Four-year-old DH exhibited the highest content of active compounds and significantly alleviated motor deficits in PD mice. It reduced oxidative stress and neuroinflammation by suppressing the NF-κB/NLRP3 pathway and activating the HO-1/Nrf2 antioxidant pathway. DH exerts neuroprotective effects against PD through dual regulation of the HO-1/Nrf2 and NF-κB/NLRP3 pathways, with efficacy enhanced by longer growth periods. These findings support DH's potential as a therapeutic agent for PD.
This connects to 11 other discoveries — 2 species, 4 topics, 5 related articles